Streetbeat News

ABL

Abacus Life, Inc.

https://abacuslife.com

Industry

Insurance - Life

Abacus Life, Inc. operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.

Open

8.63

Mkt cap

658M

Volume

45K

High

9.24

P/E Ratio

-62.93

52-wk high

13.25

Low

8.63

Div yield

N/A

52-wk low

5.75

Northland Capital Markets has initiated coverage on Abacus Life (NASDAQ:ABL) with an Outperform rating and set a price target of $13.5.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 5:05 pm

Abacus Life has announced preliminary Q3 total revenue between $26 million and $28 million, which is below the estimated $29.256 million.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:28 pm

The article corrects the ticker symbol for Abacus Life, clarifying that the correct ticker is 'ABL'.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:28 pm

Abacus Life, Inc. (NASDAQ: ABL) announced preliminary Q3 2024 results, expecting revenue between $26M-$28M, a 23-33% YoY growth. However, a non-cash increase in warrant liability is expected to result in a GAAP net loss of $6M-$6.75M. Adjusted EBITDA is projected to grow 30-48% YoY.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:27 pm

Abacus Life has filed with the SEC for a mixed shelf offering of up to $350 million. This move allows the company to offer various securities, such as debt or equity, over time. The filing provides flexibility for future capital raising.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 4:39 pm

B. Riley Securities has reiterated its Buy rating on Abacus Life (NASDAQ:ABL) and increased the price target from $15 to $16, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 2:28 pm

Abacus Life, Inc. (NASDAQ: ABL) and Lorisco Life LLC have announced the launch of PREADISAN™, a health prediction platform that uses machine learning and proteomics to improve health predictions. This partnership aims to enhance Abacus' longevity and actuarial technology services by providing more personalized risk scores.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:06 pm

Abacus Life shares are trading higher after the company reported better-than-expected Q2 adjusted EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:10 pm

Abacus Life (NASDAQ:ABL) reported Q2 2024 earnings of $0.18 per share, beating the analyst estimate of $0.12 by 50%. Sales were $29.076M, surpassing the $26.162M estimate and showing a 155.52% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 11:05 am

TD Cowen has initiated coverage on Abacus Life (NASDAQ:ABL) with a Buy rating and set a price target of $14.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:03 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.